International Journal of Experimental Pathology · 2006 · 29 citations · 33 references
MedicinePathobiologyPathologyImmunopathologyInflammationNeuroimmunologyBlood-brain Barrier BiologyBlood-brain Barrier DysfunctionCentral Nervous System InfectionsInflammatory MediatorsNeuroinflammationBlood-meningeal BarrierMatrix Metalloproteinase-mediated Barrier BreakdownMatrix Metalloproteinase-mediated Barrier DisruptionMatrix MetalloproteinasesPathological Barrier BreakdownPlasminogen ActivatorsProteolytic ActivitySubarachnoid Space
Blood-central nervous system (blood-CNS) barrier breakdown, an important pathophysiological event in meningitis, results in extravasation of leucocytes into subarachnoid space. The blood-CNS barrier disruption is mediated by primarily two enzyme systems, the plasminogen activators (PAs) and matrix metalloproteinases (MMPs). The present study showed that the activities of tissue-type PA (tPA), urokinase-type activator (uPA) and MMP-9 in cerebrospinal-like fluid (CSF-like fluid) were significantly increased in mice with eosinophilic meningitis compared with uninfected mice. Eosinophilia significantly correlated with tPA, uPA and MMP-9 activities, and albumin concentration. In addition, when GM6001, a specific matrix metalloproteinase blocker, was injected into infected mice, MMP-9 activity and total protein concentrations declined from their preinjection highs. These results suggest that the PAs and MMP-9 proteolytic cascade may be associated with blood-CNS barrier disruption in eosinophilic meningitis caused by Angiostrongylus cantonensis.
33
Development of the blood-brain barrier
Werner Risau, Hartwig Wolburg · Trends in Neurosciences · 1990 · 535 citations
Medicine, Developmental Biology, Developmental Neurobiology +10